Ten-peptide with antioxidant activity

By synthesizing and detecting a decapeptide with the amino acid sequence APKTLPWGPK, the problem of antioxidants in the prevention and treatment of oxidative stress diseases in the existing technology has been solved, achieving a highly efficient antioxidant effect and applying it to the development of antioxidants.

CN121159632APending Publication Date: 2025-12-19CHONGQING UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511202706.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-08-22
Publication Date
2025-12-19

AI Technical Summary

Technical Problem

In the current technology, the development of antioxidants has not effectively solved the prevention and treatment of oxidative stress-related diseases, especially the prevention and treatment of chronic diseases such as Alzheimer's disease, hypertension and Parkinson's syndrome caused by the imbalance between ROS production and clearance.

Method used

A decapeptide with the amino acid sequence APKTLPWGPK was developed. It was synthesized using a peptide synthesizer and analyzed by HPLC and mass spectrometry to ensure purity and molecular weight. Its antioxidant activity was determined using ABTS free radical scavenging ability, with an IC50 value of 11.06 μg/mL, indicating that it has high antioxidant performance.

Benefits of technology

This decapeptide can effectively scavenge excess reactive oxygen species, reduce oxidative stress damage, and has significant antioxidant activity, making it suitable for the prevention and treatment of oxidative stress-related diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BSA0000301541690000021
    Figure BSA0000301541690000021
  • Figure HSA0000301541700000011
    Figure HSA0000301541700000011
  • Figure HSA0000301541700000021
    Figure HSA0000301541700000021
Patent Text Reader

Abstract

The invention discloses decapeptide with antioxidant activity, the amino acid sequence of the decapeptide is amino terminal-APKTLPWGPK-carboxyl terminal, and the decapeptide can be developed into an antioxidant.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to the field of peptide biotechnology, and particularly relates to a decapeptide with antioxidant activity. BACKGROUND

[0002] Excessive accumulation of reactive oxygen species (ROS) can trigger oxidative stress. Under normal physiological conditions, the antioxidant defense system of the human body can maintain the dynamic balance of ROS content. However, with the increase of age and the stimulation of external environmental factors (such as pollution, radiation, improper diet, mental stress, etc.), the production and clearance process of ROS is imbalanced, leading to cell oxidative stress damage, thereby inducing Alzheimer's disease, hypertension, Parkinson's syndrome, cancer and other chronic diseases. Studies have shown that antioxidant peptides as a supplement to antioxidants can effectively scavenge excess ROS and reduce oxidative stress damage, and show good application potential in the prevention and treatment of oxidative stress-related diseases. In recent years, food-derived antioxidant peptides have attracted more and more research attention due to their wide sources, high safety, low toxicity and good biological activity. SUMMARY

[0003] The present application provides a decapeptide with antioxidant activity, and the amino acid sequence thereof is: amino terminal-APKTLPWGPK-carboxyl terminal, which can be developed as an antioxidant. BRIEF DESCRIPTION OF DRAWINGS

[0004] In order to make the purpose, technical scheme and advantages of the present application clearer, the present application will be further described in detail below with reference to the drawings, in which:

[0005] Figure 1 is a mass spectrum of the antioxidant decapeptide APKTLPWGPK.

[0006] Figure 2 is an HPLC graph of the antioxidant decapeptide APKTLPWGPK.

[0007] Figure 3 is an ABTS free radical scavenging capacity determination graph of the antioxidant decapeptide APKTLPWGPK. DETAILED DESCRIPTION

[0008] A series of polypeptide sequences are separated and identified from the enzymatic hydrolysate of duck embryos, and the present application peptide is identified. The antioxidant activity thereof is detected by ABTS free radical scavenging experiment.

[0009] Specific operation is: select healthy fertilized duck eggs after 15 days of incubation sample, homogenate and freeze-drying, grinding after degreasing 3-5 times with petroleum ether, then reconstituted with 0.9% saline, centrifugation and filtration with ≤3kDa ultrafiltration membrane, freeze-drying to obtain low molecular weight duck embryo polypeptide powder. Take part of the freeze-dried powder liquid nitrogen grinding, ultrasonic crushing 3-8min, centrifugal collection supernatant after precipitated twice with cold acetone (containing 10mM DTT), air-drying after dissolving with 8M Urea (containing 50mM Tris buffer, pH = 8), quantitative protein. Take 30ug protein for SDS-PAGE detection relative molecular weight. Again take 100ug protein plus trypsin (0.3% formic acid dissolution, 1ug / ul) and 0.1M triethylamine-carbonate buffer, 37 degrees C enzymolysis 16h, C18 desalination, LC-MS / MS analysis, identified to obtain the peptide, the amino acid sequence is: amino terminal-APKTLPWGPK-carboxyl terminal.

[0010] The peptide is artificially synthesized by polypeptide synthesizer, and analyzed by HPLC and Agilent-6125B mass spectrometer. The peptide segment prepared by the application has a molecular weight of 1094.28Da, as shown in Figure 1 , and a purity of 96.15%, as shown in Figure 2 , which can be used for subsequent detection.

[0011] The IC50 value of ABTS free radical scavenging capacity is used as an antioxidant index to detect its antioxidant activity. The ABTS free radical scavenging capacity determination process is as follows: ABTS is mixed with potassium persulfate solution at a ratio of 1:1, and the mixture is avoided light for 12h to generate ABTS free radical cations, and then diluted with phosphate buffer (pH = 6.6) to adjust the absorbance at 734nm to 0.7±0.2; 0.2mL of sample solution with different concentrations is mixed with 2mL of ABTS working solution, and the mixture is incubated in a warm room for 6min in the dark, and the absorbance As at 734nm is measured. At the same time, the absorbance Ab of the blank experiment is measured by replacing ABTS working solution with phosphate buffer, and the absorbance Ac of the control experiment is measured by replacing the sample solution with distilled water. The ABTS free radical scavenging rate is calculated by the following formula:

[0012]

[0013] In the formula: Ac-absorbance of the control group;

[0014] As-absorbance of the sample group

[0015] Ab-absorbance of the blank group.

[0016] From Figure 3It can be concluded that the IC50 value of the peptide in the ABTS free radical scavenging experiment is 11.06 μg / mL, indicating that the peptide has high antioxidant activity, and the amino acid sequence thereof is: amino-terminal-APKTLPWGPK-carboxyl-terminal.

[0017] The above merely illustrates the preferred embodiments of the present application, and is not intended to limit the present application. Obviously, various modifications and variations of the present application can be made by those skilled in the art without departing from the spirit and scope of the present application. Thus, if these modifications and variations of the present application fall within the scope of the present application claims and their equivalent technologies, the present application is also intended to include these modifications and variations.

Claims

1. A decapeptide with antioxidant activity, characterized in that... Its amino acid sequence is: amino-terminal-APKTLPWGPK-carboxyl-terminal.